AtaiBeckley Inc. cotiza a 7.35 USD y tiene una capitalización bursátil de $2.7B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments. The company develops rapid-acting and durable therapies for conditions with limited treatment options. Its pipeline includes BPL-003 (mebufotenin benzoate), an intranasa…
| Periodo | 2026-11 |
|---|---|
| Real | — |
| Estimado | $-0.12 |
| Sorpresa | — |
| Métrica | ATAI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -15751.1% | -38.6% | -15712.4% |
| Net Margin | -16142.0% | -33.6% | -16108.5% |
| FCF Margin | -2533.0% | -13.9% | -2519.2% |
| ROE | -297.5% | -40.4% | -257.1% |
| ROA | -225.5% | -32.0% | -193.5% |
| Current Ratio | 11.74 | 2.84 | +8.90 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |